[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

NRT Smoking Cessation Aids - Romania

May 2010 | 38 pages | ID: N1BDCE7C7E0EN
Euromonitor International Ltd

US$ 900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Nicorette was the main NRT smoking cessation aid in Romania at the end of the review period, and saw saw a 60% increase in sales in 2009. It started to gain popularity amongst Romanian consumers in 2007 due to an increasing number of programmes meant to reduce smoking and to the new legislation towards smoking. Romania’s membership of the EU led to changes in legislation, which amongst other things, banned smoking in enclosed public places and permitted smoking only in properly isolated and...

Euromonitor International's NRT Smoking Cessation Aids Products in Romania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Nrt Smoking Cessation Aids in Romania
Euromonitor International
May 2010
List of Contents and Tables
Executive Summary
Self-medication Is on the Increase
Growth Slows Down in Context of the Economic Situation
Consumer Healthcare Is Dominated by Domestic Producers
Chemists/pharmacies Maintains Its Dominance
Changing Lifestyles Increase Consumer Healthcare Consumption
Key Trends and Developments
Ageing Population Impacts Consumer Healthcare's Performance
Changes in Consumer Lifestyle Encourages More Self-medication
Consumer Healthcare Remains Highly Regulated
Modernisation of Pharmacies Contributes To Sales Growth
Domestic Producers Lead Consumer Healthcare
Rural Areas Represent Strong Growth Potential
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2009
Definitions
Analgesics
Cough, Cold and Allergy (hay Fever) Remedies
Digestive Remedies
Medicated Skin Care
Nrt Smoking Cessation Aids
Eye Care
Ear Care
Adult Mouth Care
Calming and Sleeping Products
Wound Treatments
OTC Obesity
Emergency Contraception
OTC Statins
OTC Triptans
Vitamins and Dietary Supplements
Slimming Products
Sports Nutrition Products
Herbal/traditional Products
Summary 2 Research Sources
Antibiotice SA
Strategic Direction
Key Facts
Summary 3 Antibiotice SA: Key Facts
Summary 4 Antibiotice SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Antibiotice SA: Competitive Position 2009
Biofarm SA
Strategic Direction
Key Facts
Summary 6 Biofarm SA: Key Facts
Summary 7 Biofarm SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 8 Biofarm SA: Competitive Position 2009
Ozone Laboratories SRL
Strategic Direction
Key Facts
Summary 9 Ozone Laboratories SRL: Key Facts
Summary 10 Ozone Laboratories SRL: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Ozone Laboratories SRL: Competitive Position 2009
Terapia Ranbaxy
Strategic Direction
Key Facts
Summary 12 Terapia Ranbaxy: Key Facts
Summary 13 Terapia Ranbaxy: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 14 Terapia Ranbaxy: Competitive Position 2009
Zentiva SA
Strategic Direction
Key Facts
Summary 15 Zentiva SA: Key Facts
Summary 16 Zentiva SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 17 Zentiva SA: Competitive Position 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 11 Sales of Smoking Cessation Aids by Subsector: Value 2004-2009
Table 12 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2004-2009
Table 13 NRT Gum Flavours: % Value Breakdown 2006-2009
Table 14 Smoking Cessation Aids Company Shares by Value 2005-2009
Table 15 Smoking Cessation Aids Brand Shares by Value 2006-2009
Table 16 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2009-2014
Table 17 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2009-2014


More Publications